BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 33406814)

  • 1. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia.
    Birsen R; Larrue C; Decroocq J; Johnson N; Guiraud N; Gotanegre M; Cantero-Aguilar L; Grignano E; Huynh T; Fontenay M; Kosmider O; Mayeux P; Chapuis N; Sarry JE; Tamburini J; Bouscary D
    Haematologica; 2022 Feb; 107(2):403-416. PubMed ID: 33406814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of PRIMA-1
    Maslah N; Salomao N; Drevon L; Verger E; Partouche N; Ly P; Aubin P; Naoui N; Schlageter MH; Bally C; Miekoutima E; Rahmé R; Lehmann-Che J; Ades L; Fenaux P; Cassinat B; Giraudier S
    Haematologica; 2020 Jun; 105(6):1539-1551. PubMed ID: 31488557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Ferroptosis Inducers and Inhibitors on Cell Proliferation in Acute Leukemia.
    Kumada H; Itoh M; Tohda S
    Anticancer Res; 2024 Mar; 44(3):1003-1010. PubMed ID: 38423654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial regulation of GPX4 inhibition-mediated ferroptosis in acute myeloid leukemia.
    Akiyama H; Zhao R; Ostermann LB; Li Z; Tcheng M; Yazdani SJ; Moayed A; Pryor ML; Slngh S; Baran N; Ayoub E; Nishida Y; Mak PY; Ruvolo VR; Carter BZ; Schimmer AD; Andreeff M; Ishizawa J
    Leukemia; 2024 Apr; 38(4):729-740. PubMed ID: 38148395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-leukaemic effects induced by APR-246 are dependent on induction of oxidative stress and the NFE2L2/HMOX1 axis that can be targeted by PI3K and mTOR inhibitors in acute myeloid leukaemia cells.
    Ali D; Mohammad DK; Mujahed H; Jonson-Videsäter K; Nore B; Paul C; Lehmann S
    Br J Haematol; 2016 Jul; 174(1):117-26. PubMed ID: 26991755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basic mechanisms and novel potential therapeutic targets for ferroptosis in acute myeloid leukemia.
    Tang X; Wang Y; Zhu Y; Guo Y; Liu B
    Ann Hematol; 2023 Aug; 102(8):1985-1999. PubMed ID: 37314462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin.
    Du J; Wang T; Li Y; Zhou Y; Wang X; Yu X; Ren X; An Y; Wu Y; Sun W; Fan W; Zhu Q; Wang Y; Tong X
    Free Radic Biol Med; 2019 Feb; 131():356-369. PubMed ID: 30557609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
    Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
    Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nonessential amino acid cysteine is required to prevent ferroptosis in acute myeloid leukemia.
    Cunningham A; Oudejans LL; Geugien M; Pereira-Martins DA; Wierenga ATJ; Erdem A; Sternadt D; Huls G; Schuringa JJ
    Blood Adv; 2024 Jan; 8(1):56-69. PubMed ID: 37906522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APR-246 exhibits anti-leukemic activity and synergism with conventional chemotherapeutic drugs in acute myeloid leukemia cells.
    Ali D; Jönsson-Videsäter K; Deneberg S; Bengtzén S; Nahi H; Paul C; Lehmann S
    Eur J Haematol; 2011 Mar; 86(3):206-15. PubMed ID: 21114538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT1 inhibition promotes ferroptosis sensitivity via ACSL1 upregulation in acute myeloid leukemia.
    Zhou L; Jia X; Shang Y; Sun Y; Liu Z; Liu J; Jiang W; Deng S; Yao Q; Chen J; Li H
    Mol Carcinog; 2023 Aug; 62(8):1119-1135. PubMed ID: 37144835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CircKDM4C upregulates P53 by sponging hsa-let-7b-5p to induce ferroptosis in acute myeloid leukemia.
    Dong LH; Huang JJ; Zu P; Liu J; Gao X; Du JW; Li YF
    Environ Toxicol; 2021 Jul; 36(7):1288-1302. PubMed ID: 33733556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Typhaneoside prevents acute myeloid leukemia (AML) through suppressing proliferation and inducing ferroptosis associated with autophagy.
    Zhu HY; Huang ZX; Chen GQ; Sheng F; Zheng YS
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1265-1271. PubMed ID: 31301767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro.
    Li Q; Peng F; Yan X; Chen Y; Zhou J; Wu S; Jiang W; Jin X; Liang J; Peng C; Pan X
    J Ethnopharmacol; 2023 Mar; 303():116029. PubMed ID: 36503029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune Response.
    Pitts HA; Cheng CK; Cheung JS; Sun MK; Yung YL; Chan HY; Wong RSM; Yip SF; Lau KN; Wong WS; Raghupathy R; Chan NPH; Ng MHL
    Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new therapeutic perspective: Erastin inhibits tumor progression by driving ferroptosis in myelodysplastic syndromes.
    Li J; Ma J; Zhang R; Zhai Y; Zhang W; Fu R
    J Investig Med; 2024 May; ():10815589241246541. PubMed ID: 38557364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferroptosis: process and function.
    Xie Y; Hou W; Song X; Yu Y; Huang J; Sun X; Kang R; Tang D
    Cell Death Differ; 2016 Mar; 23(3):369-79. PubMed ID: 26794443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyphyllin I induces rapid ferroptosis in acute myeloid leukemia through simultaneous targeting PI3K/SREBP-1/SCD1 axis and triggering of lipid peroxidation.
    Zhou X; Zhang D; Lei J; Ren J; Yang B; Cao Z; Guo C; Li Y
    J Nat Med; 2024 Jun; 78(3):618-632. PubMed ID: 38668832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis in acute leukemia.
    Lyu T; Li X; Song Y
    Chin Med J (Engl); 2023 Apr; 136(8):886-898. PubMed ID: 37010259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eprenetapopt Plus Azacitidine in
    Cluzeau T; Sebert M; Rahmé R; Cuzzubbo S; Lehmann-Che J; Madelaine I; Peterlin P; Bève B; Attalah H; Chermat F; Miekoutima E; Rauzy OB; Recher C; Stamatoullas A; Willems L; Raffoux E; Berthon C; Quesnel B; Loschi M; Carpentier AF; Sallman DA; Komrokji R; Walter-Petrich A; Chevret S; Ades L; Fenaux P
    J Clin Oncol; 2021 May; 39(14):1575-1583. PubMed ID: 33600210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.